Search alternatives:
significant time » significant threat (Expand Search), significant cause (Expand Search), significant gap (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
time based » home based (Expand Search)
significant time » significant threat (Expand Search), significant cause (Expand Search), significant gap (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
time based » home based (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Full list of proteins significantly enriched by BioID2 labelling.
Published 2020“…Proteins enriched on average less than three times are highlighted in blue.</p> <p>(XLSX)</p>…”
-
14
-
15
-
16
Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.
Published 2023“…<p>Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.…”
-
17
Top 10 significantly changed metabolites and lipids in each clinical outcome measure group.
Published 2023“…The orange color indicates increase in levels and the blue color represent decrease in levels. (A) MMS status, yes vs. no (B) change in (Δ) QMG (> 40% vs. < 0%) (C) change in (Δ) MG-ADL (> 40% vs. < 0%), (D) Responder versus Non-Responder. …”
-
18
-
19
Time Course of the RAAS.
Published 2025“…REN levels increased significantly from baseline at 1-month visit (4.15 ± 7.35 vs. 2.75 ± 8.03 ng/L; DKD vs. non-DKD; between-group difference, <i>p</i> < 0.05), while ARR values decreased significantly from baseline at 1-month visit (−0.70 ± 1.16 vs. −0.59 ± 1.19; between‑group difference, <i>p</i> > 0.05) and 3-month visit (−0.45 ± 1.15 vs. −0.42 ± 1.07; between‑group difference, <i>p</i> > 0.05) in both groups (within‑group change vs. baseline, <i>p</i> < 0.017). …”
-
20